Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers

Journal of Pathology

Volumn 238, Issue 4, 2016, Pages 531-542

  Zhu, Ruixin ^a   Baker, Susan S ^b   Moylan, Cynthia A ^c,d   Abdelmalek, Manal F ^c   Guy, Cynthia D ^c   Zamboni, Fausto ^e   Wu, Dingfeng ^a   Lin, Weili ^a   Liu, Wensheng ^b   Baker, Robert D ^b   Govindarajan, Sugantha ^f   Cao, Zhiwei ^a   Farci, Patrizia ^g   Diehl, Anna Mae ^c   Zhu, Lixin ^b  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e BROTZU HOSPITAL   (Italy)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

ADH; ALDH; CYP2E1; non alcoholic

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 1B; ALCOHOL DEHYDROGENASE 7; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER A1; ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER A3; ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER B1; ALDEHYDE DEHYDROGENASE 3 FAMILY MEMBER B1; ALDEHYDE DEHYDROGENASE 4 FAMILY MEMBER A1; ALDEHYDE DEHYDROGENASE 7 FAMILY MEMBER A1; ALDEHYDE DEHYDROGENASE 8 FAMILY MEMBER A1; ALDEHYDE DEHYDROGENASE 9 FAMILY MEMBER A1; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CATALASE; CYTOCHROME P450 2E1; DEATH RECEPTOR 4; DEATH RECEPTOR 5; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; PERILIPIN; PERILIPIN 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; ALCOHOL DERIVATIVE;

ADULT; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; ENZYME BLOOD LEVEL; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; BIOPSY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY; PROCEDURES;

ADULT; ALCOHOLS; BIOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; TRANSCRIPTOME;

EID: 84959090577     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4650     Document Type: Article

References (48)

1. Vernon G, Baranova A, Younossi ZM,. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
2. Charlton MR, Burns JM, Pedersen RA, et al,. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
3. Bugianesi E, McCullough AJ, Marchesini G,. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42: 987-1000.
4. Zhu L, Baker SS, Liu W, et al,. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism 2011; 60: 1001-1011.
5. Day CP, James OF,. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998; 114: 842-845.
6. Desai S, Baker SS, Liu W, et al,. Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis. Liver Int 2014; 34: 110-117.
7. Zhu L, Baker SS, Gill C, et al,. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013; 57: 601-609.
8. Yuan J, Baker SS, Liu W, et al,. Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2014; 29: 1292-1298.
9. Baker SS, Baker RD, Liu W, et al,. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One 2010; 5: e9570.
10. Cope K, Risby T, Diehl AM,. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000; 119: 1340-1347.
11. Volynets V, Kuper MA, Strahl S, et al,. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012; 57: 1932-1941.
12. Moylan CA, Pang H, Dellinger A, et al,. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 2014; 59: 471-482.
13. Lopez-Vicario C, Gonzalez-Periz A, Rius B, et al,. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut 2014; 63: 344-355.
14. Arendt BM, Comelli EM, Ma DW, et al,. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology 2015; 61: 1565-1578.
15. Ahrens M, Ammerpohl O, von Schonfels W, et al,. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab 2013; 18: 296-302.
16. Farci P, Diaz G, Chen Z, et al,. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A 2010; 107: 8766-8771.
17. Nissim O, Melis M, Diaz G, et al,. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One 2012; 7: e49611.
18. Kleiner DE, Brunt EM, Van Natta M, et al,. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
19. Affo S, Dominguez M, Lozano JJ, et al,. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 2013; 62: 452-460.
20. Hubbell E, Liu WM, Mei R,. Robust estimators for expression analysis. Bioinformatics 2002; 18: 1585-1592.
21. Eisenberg E, Levanon EY,. Human housekeeping genes, revisited. Trends Genet 2013; 29: 569-574.
22. Garcia-Ruiz C, Baulies A, Mari M, et al,. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res 2013; 47: 854-868.
23. Alkhouri N, Carter-Kent C, Feldstein AE,. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev Gastroenterol Hepatol 2011; 5: 201-212.
24. Mutsaers SE, Bishop JE, McGrouther G, et al,. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29: 5-17.
25. Goh VJ, Silver DL,. The lipid droplet as a potential therapeutic target in NAFLD. Semin Liver Dis 2013; 33: 312-320.
26. Fujii H, Ikura Y, Arimoto J, et al,. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J Atheroscler Thromb 2009; 16: 893-901.
27. Perlemuter G, Davit-Spraul A, Cosson C, et al,. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int 2005; 25: 946-953.
28. Chalasani N, Gorski JC, Asghar MS, et al,. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003; 37: 544-550.
29. Dufour JH, Dziejman M, Liu MT, et al,. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-3204.
30. Bertola A, Bonnafous S, Anty R, et al,. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One 2010; 5: e13577.
31. Crabb DW, Matsumoto M, Chang D, et al,. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004; 63: 49-63.
32. Begriche K, Igoudjil A, Pessayre D, et al,. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28.
33. Boujedidi H, Bouchet-Delbos L, Cassard-Doulcier AM, et al,. Housekeeping gene variability in the liver of alcoholic patients. Alcohol Clin Exp Res 2012; 36: 258-266.
34. Feldstein AE, Canbay A, Angulo P, et al,. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437-443.
35. Syn WK, Choi SS, Diehl AM,. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis 2009; 13: 565-580.
36. Faubion WA, Gores GJ,. Death receptors in liver biology and pathobiology. Hepatology 1999; 29: 1-4.
37. Diehl AM, Goodman Z, Ishak KG,. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-1062.
38. Lieber CS, Lasker JM, DeCarli LM, et al,. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system. J Pharmacol Exp Ther 1988; 247: 791-795.
39. Michail S, Kenche H, Homer DC, et al,. Gut microbial profile in pediatric non-alcoholic fatty liver disease. Gastroenterology 2011; 140: S-118.
40. O'Brien MJ, Keating NM, Elderiny S, et al,. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 2000; 114: 712-718.
41. Tsutsumi M, Lasker JM, Shimizu M, et al,. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989; 10: 437-446.
42. Takahashi T, Lasker JM, Rosman AS, et al,. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993; 17: 236-245.
43. Colmenero J, Bataller R, Sancho-Bru P, et al,. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007; 132: 687-697.
44. Liangpunsakul S, Chalasani N,. What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 2012; 107: 976-978.
45. Giebultowicz J, Solobodowska S, Bobilewicz D, et al,. Blood ALDH1 and GST activity in diabetes type 2 and its correlation with glycated hemoglobin. Exp Clin Endocrinol Diabetes 2014; 122: 55-59.
46. Stepanova M, Hossain N, Afendy A, et al,. Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Obes Surg 2010; 20: 640-650.
47. Younossi ZM, Gorreta F, Ong JP, et al,. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 2005; 25: 760-771.
48. Chrostek L, Jelski W, Szmitkowski M, et al,. Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 2003; 17: 93-96.